| scholarly article | Q13442814 |
| P2093 | author name string | C Harteneck | |
| G Schultz | |||
| D Koesling | |||
| J Foerster | |||
| J Malkewitz | |||
| P2860 | cites work | A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 |
| Characterization of heme-deficient neuronal nitric-oxide synthase reveals a role for heme in subunit dimerization and binding of the amino acid substrate and tetrahydrobiopterin. | Q30423824 | ||
| Guanylyl cyclase receptors | Q40365798 | ||
| Expression of soluble guanylyl cyclase. Catalytic activity requires two enzyme subunits | Q41718282 | ||
| Functional domains of soluble guanylyl cyclase | Q42065567 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 380-386 | |
| P577 | publication date | 1996-09-01 | |
| P1433 | published in | FEBS Journal | Q1388041 |
| P1476 | title | A functional heme-binding site of soluble guanylyl cyclase requires intact N-termini of alpha 1 and beta 1 subunits. | |
| P478 | volume | 240 |
| Q35234315 | A constitutively activated mutant of human soluble guanylyl cyclase (sGC): implication for the mechanism of sGC activation |
| Q40673658 | A functional domain of the alpha1 subunit of soluble guanylyl cyclase is necessary for activation of the enzyme by nitric oxide and YC-1 but is not involved in heme binding. |
| Q54357894 | A novel insight into the heme and NO/CO binding mechanism of the alpha subunit of human soluble guanylate cyclase. |
| Q42049434 | A-350619: a novel activator of soluble guanylyl cyclase |
| Q24798253 | Ancient conserved domains shared by animal soluble guanylyl cyclases and bacterial signaling proteins |
| Q42523405 | Biliverdin IX is an endogenous inhibitor of soluble guanylyl cyclase. |
| Q28379365 | Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase |
| Q35776824 | Cobinamides are novel coactivators of nitric oxide receptor that target soluble guanylyl cyclase catalytic domain |
| Q40450190 | Dimerization of nitric oxide-sensitive guanylyl cyclase requires the alpha 1 N terminus. |
| Q39847509 | Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation |
| Q33824523 | Evidence for cross-talk between atrial natriuretic peptide and nitric oxide receptors |
| Q28368954 | Functional properties of a naturally occurring isoform of soluble guanylyl cyclase |
| Q37136078 | Guanylyl cyclases: approaching year thirty |
| Q35783161 | Heterogeneous nuclear ribonucleoprotein A1 is a novel cellular target of atrial natriuretic peptide signaling in renal epithelial cells |
| Q42058515 | Homodimerization of soluble guanylyl cyclase subunits. Dimerization analysis using a glutathione s-transferase affinity tag. |
| Q44626758 | Identification of residues crucially involved in the binding of the heme moiety of soluble guanylate cyclase |
| Q28392601 | Implication of microRNAs in atrial natriuretic peptide and nitric oxide signaling in vascular smooth muscle cells |
| Q43972677 | Inhibition of deactivation of NO-sensitive guanylyl cyclase accounts for the sensitizing effect of YC-1. |
| Q46261374 | Irreversible activation and stabilization of soluble guanylate cyclase by the protoporphyrin IX mimetic cinaciguat. |
| Q34599889 | Isoforms of NO-sensitive guanylyl cyclase |
| Q34106000 | Molecular aspects of soluble guanylyl cyclase regulation |
| Q24656131 | NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential |
| Q40799534 | Nitric oxide activates the beta 2 subunit of soluble guanylyl cyclase in the absence of a second subunit |
| Q38151386 | Nitric oxide-sensing H-NOX proteins govern bacterial communal behavior |
| Q36532454 | Pathophysiology of hypertension in the absence of nitric oxide/cyclic GMP signaling |
| Q44577972 | Preparation of heme-free soluble guanylate cyclase |
| Q39504233 | Probing the presence of the ligand-binding haem in cellular nitric oxide receptors |
| Q49789143 | Redox control of vascular smooth muscle cell function and plasticity. |
| Q43656867 | Regional and age-dependent expression of the nitric oxide receptor, soluble guanylyl cyclase, in the human brain |
| Q35704136 | Regulation of nitric oxide and soluble guanylyl cyclase |
| Q43823331 | Role of conformational changes in the heme-dependent regulation of human soluble guanylate cyclase |
| Q37537154 | Role of guanylate cyclase modulators in decompensated heart failure |
| Q28379416 | Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme |
| Q91844284 | Smooth muscle cytochrome b5 reductase 3 deficiency accelerates pulmonary hypertension development in sickle cell mice |
| Q37826122 | Soluble guanylate cyclase modulators in heart failure |
| Q41698395 | Soluble guanylate cyclase: the forgotten sibling. |
| Q38318731 | Soluble guanylyl cyclase: the nitric oxide receptor |
| Q41963144 | Stimulation of soluble guanylate cyclase by superoxide dismutase is mediated by NO. |
| Q39790834 | The beta2 subunit inhibits stimulation of the alpha1/beta1 form of soluble guanylyl cyclase by nitric oxide. Potential relevance to regulation of blood pressure |
| Q34042836 | The fibrate gemfibrozil is a NO- and haem-independent activator of soluble guanylyl cyclase: in vitro studies |
| Q34599899 | The receptor-like properties of nitric oxide-activated soluble guanylyl cyclase in intact cells. |
| Q38896087 | The role of cGMP and its signaling pathways in kidney disease |
Search more.